Igalelo lethu eliphambili kukuba unyango oluphezulu lukhuphile ukudibanisa izibonelelo zonyango lwe-chemotherapy kunye nemmunoherapy, okokuqala, zombini zidityanisiwe kwaye zasetyenziswa kwi-Intratoral Popy. It integrates local and global treatment, and increases the concentration and time of drug action through sustained release of drugs within the tumor, which not only plays a local anticancer effect of chemotherapy drugs, but also takes into account the role of systemic immunotherapy, thus making up for the shortcomings of other therapies, providing new ideas and approaches for cancer treatment, especially for middle and advanced tumors, especially for reducing tumor recurrence and inhibiting tumar Udluliselo lunexabiso elibaluleke kakhulu; Unyango lwe-Umpic lunesibonelelo sokusebenzisa ithumba njenge-Antign Musine kunye nogonyo logonyo lwe-ANGOGO, olukwinqanaba lokuphucula amayeza awodwa. Kwaye ifakwe kwikliniki, idityaniswe ne-Chemotherapy iziyobisi zokukhutshwa kwe-pancreatic yomhlaza wokugxila kwi-AAMOANEICING: I-CD8 ye-TUMOOCEGOUGE: I-Koc, osindileyo, i-P62, i-H62, i-HCC1 kunye nabanye oonobumba, i-CORTE YENKONZO YOBUCHWEPHESHONO SOKUGQIBELA I-National General Accoventity i-Innovance yapapashwa kwi

Ijenali yeRadicalogy, uMqulu 43, inombolo 19, 2024, 1636-1648.